The historical rank and industry rank for Fulgent Genetics's Price-to-Tangible-Book or its related term are showing as below:
MEX:FLGT'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.63 Med: 2.03 Max: 9.11
Current: 0.63
During the past 10 years, Fulgent Genetics's highest Price to Tangible Book Ratio was 9.11. The lowest was 0.63. And the median was 2.03.
MEX:FLGT's Price-to-Tangible-Book is ranked better than 89.09% of 165
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.46
vs MEX:FLGT: 0.63
Fulgent Genetics Price-to-Tangible-Book Historical Data
The historical data trend for Fulgent Genetics's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Fulgent Genetics's Price-to-Tangible-Book
For the Diagnostics & Research subindustry, Fulgent Genetics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fulgent Genetics's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Fulgent Genetics's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Fulgent Genetics Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Fulgent Genetics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MEX:FLGT has been successfully added to your 